Sandbox/AL

Jump to navigation Jump to search

The treatment for septic arthritis requires an adequate drainage of purulent joint fluid and appropriate antimicrobial therapy. Empiric therapy should be started after the collection joint fluid and blood sample, and these should be send for culture.



Empiric Therapy Adapted from Lancet. 2012;380(9854):1693-702.[1] and Clin Infect Dis. 2004;39(9):1267-84.[2]

▸ Click on the following categories to expand treatment regimens.

Gram-Positive

  ▸  Gram-Positive Cocci in Chains

  ▸  Gram-Positive Cocci in Pairs

  ▸  Gram-Positive (Cocco-)Bacilli

Gram-Negative

  ▸  Gram-Negative Cocci in Pairs

  ▸  Gram-Negative Coccobacilli

  ▸  Gram-Negative Bacilli

Gram-Positive Cocci in Chains
Preferred Regimen
Vancomycin 15 mg/kg IV q8—12h (trough 15—20 μg/mL)
PLUS
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Alternative Regimen
Meropenem 2 g IV q8h
OR
Moxifloxacin 400 mg IV q24h
Gram-Positive Cocci in Pairs
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Alternative Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Gram-Positive (Cocco-)Bacilli
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Alternative Regimen
TMP/SMZ 5 mg/kg IV q6—12h (TMP component)
OR
Meropenem 2 g IV q8h
Gram-Negative Cocci in Pairs
Preferred Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Alternative Regimen
Penicillin G 4 MU IV q4h
OR
Ampicillin 2 g IV q4h
OR
Chloramphenicol 1—1.5 g IV q6h
OR
Moxifloxacin 400 mg IV q24h
OR
Aztreonam 2 g IV q6—8h
Gram-Negative Coccobacilli
Preferred Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Alternative Regimen
Chloramphenicol 1—1.5 g IV q6h
OR
Cefepime 2 g IV q8h
OR
Meropenem 2 g IV q8h
OR
Moxifloxacin 400 mg IV q24h
Gram-Negative Bacilli
Preferred Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Alternative Regimen
Cefepime 2 g IV q8h
OR
Meropenem 2 g IV q8h
OR
Aztreonam 2 g IV q6—8h
OR
Moxifloxacin 400 mg IV q24h
OR
TMP/SMZ 5 mg/kg IV q6—12h (TMP component)


Pathogen-Based Therapy — Bacteria Adapted from

▸ Click on the following categories to expand treatment regimens.

Bacteria

  ▸  Staphylococcus aureus

  ▸  Staphylococcus epidermidis

  ▸  Methicillin-resistant S. aureus

  ▸  Streptococcus groups A, B, C, G

  ▸  Enterococcus feacalis

Staphylococcus aureus
Preferred Regimen
Nafcillin 2 g IV q6h
Alternative Regimen
Vancomycin
OR
Cefazolin
OR
Clindamycin
Staphylococcus epidermidis
Preferred Regimen
Vancomycin 15 mg/kg IV q12h
Alternative Regimen
TMP-SMX
OR
Methicillin-resistant S. aureus
Preferred Regimen
Vancomycin 15 mg/kg IV q12h
Alternative Regimen
TMP-SMX
OR
Doxycycline
OR
Linezolid
Streptococcus groups A, B, C, G
Preferred Regimen
Penicillin G 2 MU IV q4h
Alternative Regimen
Vancomycin
OR
Cefazolin
OR
Erythromycin
Enterococcus faecalis
Preferred Regimen
Penicillin G 2 MU IV q4h
OR
Ampicillin 2 g IV q6h
PLUS
Gentamicin 1 mg/kg IV or IM q8h
Alternative Regimen
Vancomycin
PLUS
Gentamicin 1 mg/kg IV or IM q8h
N. meningitidis, Penicillin MIC ≥0.1 μg/mL
Preferred Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Alternative Regimen
Cefepime 2 g IV q8h
OR
Chloramphenicol 1—1.5 g IV q6h
OR
Moxifloxacin 400 mg IV q24h
OR
Meropenem 2 g IV q8h
Pseudomonas aeruginosa
Preferred Regimen
Ceftazidime 2 g IV q8h
OR
Cefepime 2 g IV q8h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Alternative Regimen
Aztreonam 2 g IV q6—8h
OR
Meropenem 2 g IV q8h
OR
Ciprofloxacin 400 mg IV q8—12h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Staphylococcus aureus, Methicillin sensitive
Preferred Regimen
Nafcillin 1.5—2 g IV q4h
OR
Oxacillin 1.5—2 g IV q4h
Alternative Regimen
Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
OR
Linezolid 600 mg IV q12h
OR
Daptomycin 6 mg/kg IV q24h



CSF Gram Stain-Based Therapy Adapted from

▸ Click on the following categories to expand treatment regimens.

Gram-Positive

  ▸  Gram-Positive Cocci

Gram-Negative

  ▸  Gram-Negative Cocci

  ▸  Gram-Negative Rods

  ▸  Negative Gram Stain

Gram-Positive Cocci
Preferred Regimen
Vancomycin 15-20 mg/kg IV q8—12h (trough 15—20 μg/mL)
Alternative Regimen
(For patients allergic to vancomycin)
Linezolid
OR
Daptomycin
Gram-Negative Cocci
Preferred Regimen
Ceftriaxone 1 g IV q24h
Gram-Negative Rods
Preferred Regimen
Ceftazidime 2 g IV q8h
OR
Cefepime 2g IV q12h
OR

Piperacillin-Tazobactam 4.5 g q6h
OR
Imipenem 500 mg IV q6h
OR
Meropenem 1 g IV q8h

Alternative Regimen (For patients allergic to cephalosporins)
Aztreonam 2 g q8h
OR
Ciprofloxacin 400 mg IV q12h
OR
Levofloxacin 750 mg IV q24h
Negative Gram Stain
Preferred Regimen
Vancomycin 15-20 mg/kg IV q8—12h
PLUS
Ceftazidime 2 g IV q8h
Alternative Regimen
Ciprofloxacin 750 mg IV q12h
OR
Levofloxacin 750 mg IV q24h
OR
Tobramycin
OR
Gentamycin 5-7 mg/kg once daily or 5 mg/kg divided in 3 doses/day
  1. van de Beek, D.; Brouwer, MC.; Thwaites, GE.; Tunkel, AR. (2012). "Advances in treatment of bacterial meningitis". Lancet. 380 (9854): 1693–702. doi:10.1016/S0140-6736(12)61186-6. PMID 23141618. Unknown parameter |month= ignored (help)
  2. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM et al. (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 (9):1267-84. DOI:10.1086/425368 PMID: [1]